CD28 and Cirrhosis: Markers of immunosenescence in that study were increased in cirrhosis patients compared to healthy controls (i.e., higher proportion of CD8 + CD45RO + CD57+ T-cells) and in cirrhotic patients with ascites compared to healthy controls (i.e., lower proportion of CD28+ T-cells) [25].